Anti-tumor activity, in vitro and in vivo, of some triphenylphosphinegold(I) thionucleobases

Metal-Based Drugs

Volumn 3, Issue 2, 1996, Pages 63-66

  Webster, Lorraine K ^a   Rainone, Silvina ^a   Horn, Ernst ^b   Tiekink, Edward R T ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; GOLD COMPLEX; THIOGUANINE DERIVATIVE; TRIPHENYLPHOSPHINEGOLD 6 MERCAPTOPURINE; TRIPHENYLPHOSPHINEGOLD 6 THIOGUANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; OVARY CARCINOMA; PLASMACYTOMA; SQUAMOUS CELL CARCINOMA; STRUCTURE ACTIVITY RELATION;

EID: 0030010246     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1996.63     Document Type: Article

References (21)

1. Lewis, A.J.; Walz, D.T. Prog. Med. Chem., 1982, 19, 1.
2. Sutton, B.M. Gold Bull., 1986, 19, 15.
3. Parish, R.V. Interdisciplinary Sci. Rev., 1992,17, 221.
4. Berners-Price, S.J.; Mirabelli, C.K.; Johnson, R.K.; Mattern, M.R.; McCabe, F.L.; Faucette, L.F.; Sung, C.-M.; Mong, S.-M.; Sadler, P.J.; Crooke, ST. Cancer Res., 1986, 46, 5486.
5. Berners-Price, S.J.; Girard, G.R.; Hill, D.T.; Sutton, B.M.; Jarrett, P.S.; Faucette, L.F.; Johnson, R.K.; Mirabelli, C.K.; Sadler, P.J. J.Med. Chem., 1990, 33, 1386.
6. Rush, G.F.; Alberts, D.W.; Meunier, P.; Leffler, K.; Smith, P.F. Toxiocologist, 1987, 7, 59.
7. Mirabelli, C.K.; Johnson, R.K.; Sung, C.-M.; Faucette, L.F.; Muirhead, K.; Crooke, S.T.; Cancer Res., 1985, 45, 32.
8. Arizti, M.P.; Garcia-Orad, A.; Sommer, F.; Silvestro, L.; Massiot, P.; Chevallier, P.; Gutiérrez-Zorrilla, J.M.; Colacio, E.; Martinez de Pancorbo, M.; Tapiero, H. Anticancer Res., 1991,11, 625.
9. Tiekink, E.R.T.; Cookson, P.D.; Linahan, B.M.; Webster, L.K. Metal Based Drugs, 1994, 1, 299.
10. McCormack, J.J.; Johns, D.G. in Cancer Chemotherapy: Principles and Practice, Chabner, B.A.; Collins, J.M. (Eds) Lippincott Company, Philadelphia, 1990, Chapter 9.
11. Marshall, J.L.; Andrews P.A. Hematol/Oncol Clinics N Amer., 1995, 9, 415.
12. Harker, C.S.W.; Tiekink, E.R.T.; Whitehouse, M.W. Inorg. Chim. Acta, 1991,181, 23.
13. Cookson, P.D.; Tiekink, E.R.T.; Whitehouse, M.W. Aust. J. Chem., 1994, 47, 577.
14. 3, Z= 6, R = 0.059 for 792 data.
15. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.; Bokesch, H.; Kennedy, S.; Boyd, M. J. Natl Cancer Inst, 1990, 82, 1107.
16. Kraker, A.J.; Moore, C.W. Cancer Res., 1988, 48, 9.
17. Tashiro, T.; Sato, Y. Jpn J. Cancer Res., 1992, 83, 219.
18. Richon, V.M.; Schults, N.; Eastman, A. Cancer Res., 1987, 47, 2056.
19. Simon, T.M.; Kunishima, D.H.; Vibert, G.J.; Lorber, A. Cancer Res., 1981, 41, 94.
20. Mirabelli, C.K.; Johnson, R.K.; Hill, D.T.; Faucette, L.F.; Girard, G.R.; Kuo, G.Y.; Sung, C.-M.; Crooke, S.T. J. Med. Chem., 1986, 29, 218.
21. Shaw, C.F. Gold. In: Metal Compounds in Cancer Therapy. Fricker, S.P. (Ed.). Chapman & Hall, London, 1994, pp 46 - 64.